Eric Hsieh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Eric Hsieh has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Samantha Quon
Keck Medical Center University of Southern California Los Angeles CA USA
2 shared publicationsBijan Rizi
Department of Internal Medicine University of Southern California Los Angeles California
1 shared publication- Caroline I. Piatek
Jane Anne Nohl Division of Hematology USC Norris Comprehensive Cancer Center Los Angeles California USA
1 shared publication Elizabeth Pan
Department of Medicine, Keck School of Medicine of USC, Los Angeles, California, USA
1 shared publicationJohn Donovan
Keck Medical Center University of Southern California Los Angeles CA USA
1 shared publicationJoshua Sapkin
Department of Internal Medicine University of Southern California Los Angeles CA USA
1 shared publication
Latest Publications
- Open Access
- 9 November 2021
- Published by Wiley in Clinical Case Reports
- Vol. 9 (11) , e05018
From prostate to the pons: The first reported case of multi‐organ septic emboli and brain empyema from an untreated prostate abscess
Prostate abscesses in developed countries are becoming increasingly less common. Left untreated these abscesses can lead to numerous complications, including some which are very rare.
- 9 November 2021
- Published by Wiley in Clinical Case Reports
- Vol. 9 (11) , e05018
Open AccessFrom prostate to the pons: The first reported case of multi‐organ septic emboli and brain empyema from an untreated prostate abscess
Prostate abscesses in developed countries are becoming increasingly less common. Left untreated these abscesses can lead to numerous complications, including some which are very rare.
- Open Access
- 24 August 2021
- Published by Wiley in Clinical Case Reports
- Vol. 9 (8) , e04684
Disseminated Mycobacterium bovis infection after deceased donor liver transplantation: A case report
This case demonstrates the significance, and ongoing relevance of mycobacterial infections, especially in patients who have recently been started on immunosuppression.
- 24 August 2021
- Published by Wiley in Clinical Case Reports
- Vol. 9 (8) , e04684
Open AccessDisseminated Mycobacterium bovis infection after deceased donor liver transplantation: A case report
This case demonstrates the significance, and ongoing relevance of mycobacterial infections, especially in patients who have recently been started on immunosuppression.
- Open Access
- 18 November 2019
- Published by Wiley in Clinical Case Reports
- Vol. 7 (12) , 2513-2514
Systemic lupus erythematosus presenting as Evans syndrome
Hematologic abnormalities are an important part of the diagnostic criteria for systemic lupus erythematosus (SLE). This case presents a patient diagnosed with Evans Syndrome with underlying SLE on initial presentation.
- 18 November 2019
- Published by Wiley in Clinical Case Reports
- Vol. 7 (12) , 2513-2514
Open AccessSystemic lupus erythematosus presenting as Evans syndrome
Hematologic abnormalities are an important part of the diagnostic criteria for systemic lupus erythematosus (SLE). This case presents a patient diagnosed with Evans Syndrome with underlying SLE on initial presentation.
- Open Access
- 20 December 2018
- Published by S. Karger AG in Case Reports in Oncology
- Vol. 11 (3) , 880-882
Case Report: Oxaliplatin-Induced Immune-Mediated Thrombocytopenia
Thrombocytopenia is a frequent complication of cancer may be due to a variety of causes including malignancy itself, acute disease processes, or cancer therapy. Systemic cancer therapy is the most common cause of thrombocytopenia in cancer patients observed nearly two-thirds of patients with solid tumors. Thrombocytopenia with traditional chemotherapy agents is most frequently the result of megakaryocyte cytotoxicity. Oxaliplatin is a platinum derivative commonly used in gastrointestinal malignancies and is associated with drug-induced immune thrombocytopenia.
- 20 December 2018
- Published by S. Karger AG in Case Reports in Oncology
- Vol. 11 (3) , 880-882
Open AccessCase Report: Oxaliplatin-Induced Immune-Mediated Thrombocytopenia
Thrombocytopenia is a frequent complication of cancer may be due to a variety of causes including malignancy itself, acute disease processes, or cancer therapy. Systemic cancer therapy is the most common cause of thrombocytopenia in cancer patients observed nearly two-thirds of patients with solid tumors. Thrombocytopenia with traditional chemotherapy agents is most frequently the result of megakaryocyte cytotoxicity. Oxaliplatin is a platinum derivative commonly used in gastrointestinal malignancies and is associated with drug-induced immune thrombocytopenia.
- Open Access
- 22 June 2018
- Published by Wiley in Clinical Case Reports
- Vol. 6 (8) , 1554-1556
Short‐term use of oral amiodarone causing torsades de pointes
Key Clinical Message: Amiodarone is one of the most commonly used antiarrhythmic drugs. Despite its well‐known side effects, amiodarone is considered to be a relatively safe drug, especially in short‐term usage to prevent life‐threatening ventricular arrhythmias. Our case demonstrates an instance where short‐term usage can yield drug side effect.
- 22 June 2018
- Published by Wiley in Clinical Case Reports
- Vol. 6 (8) , 1554-1556
Open AccessShort‐term use of oral amiodarone causing torsades de pointes
Key Clinical Message: Amiodarone is one of the most commonly used antiarrhythmic drugs. Despite its well‐known side effects, amiodarone is considered to be a relatively safe drug, especially in short‐term usage to prevent life‐threatening ventricular arrhythmias. Our case demonstrates an instance where short‐term usage can yield drug side effect.